Evidence map›Paper›PMID 42806837›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Transformer-Based PET/CT Fusion Enables Preoperative Prediction and Prognostic Stratification of Spread Through Air Spaces in Lung Adenocarcinoma.

Xin-Yu Zhu, Meng Meng, Zhen-Zhen Wang, Deng-Lu Lu, Ya-Min Wei, Xu-Chang Mi, Xing-Yu Mu, Wei Fu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xin-Yu ZhuDepartment of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Meng MengLaboratory Center, Guangxi Key Laboratory of Metabolic Reprogramming and Intelligent Medical Engineering for Chronic Diseases, The Second Affiliated Hospital of Guilin Medical University, Guilin, China.ORCID https://orcid.org/0000-0002-9291-3442
Zhen-Zhen WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Deng-Lu LuDepartment of Nuclear Medicine, Liuzhou Worker's Hospital, Liuzhou, China.
Ya-Min WeiDepartment of Pathology, The First Affiliated Hospital of Guilin Medical University, Guilin, China.
Xu-Chang MiDepartment of Nuclear Medicine, Nanxishan Hospital, Guilin, China.
Xing-Yu MuDepartment of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.ORCID https://orcid.org/0009-0000-3944-2728
Wei FuDepartment of Nuclear Medicine, The First Affiliated Hospital of Guilin Medical University, Guilin, China.ORCID https://orcid.org/0009-0000-5173-6331

Funding

National Natural Science Foundation of China 82402332National Natural Science Foundation of China 82460356Natural Science Foundation of Guangxi Zhuang Autonomous Region 2025GXNSFHA069001Natural Science Foundation of Guangxi Zhuang Autonomous Region 2026GXNSFBA00640100
6 · The paper itself

Abstract

Spread through air spaces (STAS) is associated with recurrence and unfavorable outcomes in lung adenocarcinoma, yet reliable preoperative identification remains challenging. This multicenter retrospective study includes 212 patients with 219 tumors across three institutions and develops a transformer-based multimodal framework integrating eight complementary 2.5D PET and CT representations for preoperative STAS risk assessment. The model achieves an area under the receiver operating characteristic curve of 0.822 (95% CI, 0.725-0.920) in the independent external test cohort, with higher discrimination than the evaluated single-modality and conventional fusion approaches. Beyond STAS classification, the continuous model-derived risk score is associated with progression-free survival after adjustment for pathological T stage, N stage, and maximum tumor diameter (HR, 4.24; 95% CI, 1.47-12.25; P = 0.008), although the limited number of progression events warrants cautious interpretation. Exploratory transcriptomic analyses across two public cohorts further nominate candidate programs involving cell adhesion, vesicle trafficking, complement activity, and metabolic remodeling. Together, these findings highlight the potential of multimodal PET/CT fusion to integrate morphological and metabolic information for noninvasive STAS risk stratification and support further prospective multicenter evaluation toward individualized surgical decision support.

Indexed as

deep learninglung adenocarcinomamultimodal fusionPET/CTprognostic biomarkerradiogenomicsspread through air spacestransformer

Identifiers

PMID42806837
PMCPMC13621198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.